“What distinguishes my research from others is that I have developed a method where I can manipulate stem cells with an extremely high degree of precision to develop into only one type of cell. This results in an exceptional quality of the desired cell,” Denham said.
“Until now, it has only been possible to develop cells that contain approximately 10% of the desired cells, while with my method I achieve a significantly higher purity,” Denham added, noting that ongoing clinical trials use an older and less efficient method to make dopaminergic neurons.
“My goal is to help patients stay off their medication, which requires high purity. So, my next step is to transfer my method to clinical trials,” Denham said.